Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. (Q53453296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Mina Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

He Wen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sunmi Kang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Hye-Ji Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Myung-Joo Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Hee Seung Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

DalWoong Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

In Suh Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Young Ju Suh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Soon-Sun Hong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sunghyouk Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

27 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

529-537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin nephrotoxicity: a review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmacogenomics: the promise of personalized medicine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Addressing the challenges of the clinical application of pharmacogenetic testing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Genetic variants associated with cisplatin-induced ototoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmacology and pharmacogenetics of chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmaco-metabonomic phenotyping and personalized drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabonomics techniques and applications to pharmaceutical research & development

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Validation of putative genomic biomarkers of nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabolomic study of cisplatin-induced nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabonomics: a platform for studying drug toxicity and gene function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Biochemical mechanisms of nephrotoxicity: application for metabolomics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabolomics in monitoring kidney transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabonomic evaluation of melamine-induced acute renal toxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Orthogonal projections to latent structures (O-PLS)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cellular processing of platinum anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin: mode of cytotoxic action and molecular basis of resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Pyridine-nucleotide oxidation, Ca2+ cycling and membrane damage during tert-butyl hydroperoxide metabolism by rat-liver mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

The reduction of diamide by rat liver mitochondria and the role of glutathione

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Physiological roles of nicotinamide nucleotide transhydrogenase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Imatinib (ST1571) provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Analytic properties of statistical total correlation spectroscopy based information recovery in 1H NMR metabolic data sets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Dynamic biochemical information recovery in spontaneous human seminal fluid reactions via 1H NMR kinetic statistical total correlation spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.440

7 January 2021

Identifiers

DOI

10.1038/KI.2010.440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json

release_oihiuf3pdvexnewzlmiyf3yr6e

14 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oihiuf3pdvexnewzlmiyf3yr6e

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20980974%20AND%20SRC:MED&resulttype=core&format=json